General Nephrology

General Medicine

AKI Risk in COVID-19 vs Flu Not Disproportionately Higher With RAASi Use

By

John Schieszer, MA

May 5, 2022

New study is the first to examine the effect of the use of renin-angiotensin-aldosterone system inhibitors on AKI in COVID-19.

Next post in General Medicine

Children’s Mental Health Impacted by Adult COVID-19 Vaccination Rates